2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole: Handling Protocol
2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole: Handling Protocol
2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole is a brominated heteroaromatic building block combining a 1,3,4-oxadiazole core with a pyridine ring, widely used as an intermediate in medicinal chemistry and drug-discovery synthesis campaigns.
- Chemical Name
- 2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole
- SKU
- B179918
- Core Scaffold
- 1,3,4-Oxadiazole fused with 3,5-disubstituted pyridine
- Key Functional Handle
- Aryl bromide (C–Br) suitable for cross-coupling reactions (Suzuki, Negishi, Buchwald–Hartwig)
- Recommended Storage
- Store in a cool, dry place away from light; seal tightly under inert atmosphere after opening
- Primary Application
- Intermediate in synthesis of bioactive oxadiazole-pyridine hybrids for pharmaceutical research
Safety and Pre-Use Precautions
Before handling 2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole (B179918), review the current Safety Data Sheet (SDS) supplied by Aladdin Scientific. As a brominated heterocyclic compound, standard precautions for organic research reagents apply:
- Wear appropriate personal protective equipment (PPE): nitrile gloves, lab coat, and safety goggles.
- Handle in a well-ventilated fume hood to minimise inhalation exposure to fine particulates or vapours.
- Avoid contact with skin, eyes, and mucous membranes.
- In the event of skin contact, wash thoroughly with soap and water; for eye contact, irrigate immediately with copious water and seek medical attention.
- Organic bromides may be irritants; treat all exposures seriously and consult the SDS for first-aid measures.
Note: Specific toxicological data for this compound have not been confirmed in the source material; consult the product SDS and exercise standard laboratory caution.
Dissolution and Solution Preparation
2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole contains both a polar oxadiazole ring and a lipophilic propyl chain, which together confer moderate polarity. The following guidance is based on the general solubility behaviour of analogous oxadiazole-pyridine compounds:
- Solvent selection: Dimethyl sulfoxide (DMSO) and N,N-dimethylformamide (DMF) are typically suitable primary solvents for initial stock solution preparation. Dichloromethane (DCM) and ethyl acetate may be used for synthetic applications.
- Stock solution preparation: Weigh the required mass accurately using an analytical balance. Dissolve in DMSO to prepare a concentrated stock (e.g. 10–100 mM), vortexing or sonicating gently until fully dissolved.
- Dilution: For biological assays, dilute the DMSO stock into aqueous buffer immediately before use; keep the final DMSO concentration ≤0.1% v/v unless validated otherwise for the assay system.
- Clarity check: Inspect the solution visually for cloudiness or precipitation before use; if precipitation is observed, warm gently or add a small volume of co-solvent.
Review flag: Specific solubility values (mg/mL) for B179918 were not provided in the source material and should be verified experimentally or confirmed with Aladdin Scientific technical support.
Synthetic Applications and Cross-Coupling Protocol
The aryl bromide functionality on the pyridine ring of 2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole makes it a versatile electrophilic partner in palladium- and nickel-catalysed cross-coupling reactions. Representative applications include:
- Suzuki–Miyaura coupling: React with aryl- or heteroarylboronic acids in the presence of a Pd catalyst (e.g. Pd(PPh₃)₄ or Pd(dppf)Cl₂) and a base (K₂CO₃ or Cs₂CO₃) in a mixed aqueous/organic solvent (e.g. DMF/H₂O or dioxane/H₂O) at 80–100 °C.
- Buchwald–Hartwig amination: Couple with primary or secondary amines using Pd₂(dba)₃ with a bulky phosphine ligand (e.g. BINAP or XPhos) and a base such as Cs₂CO₃ in toluene or dioxane at elevated temperature.
- Negishi coupling: React with organozinc reagents under Pd catalysis for C–C bond formation.
General Suzuki coupling procedure (representative):
- Charge a Schlenk flask with B179918 (1.0 equiv.), boronic acid (1.2 equiv.), Pd(PPh₃)₄ (2–5 mol%), and K₂CO₃ (2.0 equiv.).
- Add degassed DMF/H₂O (4:1 v/v) under nitrogen.
- Stir at 90 °C for 12–16 h.
- Cool, dilute with ethyl acetate, wash with brine, dry over Na₂SO₄, filter, and concentrate.
- Purify by column chromatography (silica gel) or recrystallisation.
Review flag: Specific reaction conditions, yields, and literature precedents for B179918 in cross-coupling have not been confirmed in the source material. Conditions above are general guidance for aryl bromide substrates bearing oxadiazole groups.
Storage, Stability, and Waste Disposal
Storage: Store 2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole in a tightly sealed container in a cool, dry, well-ventilated area away from direct light and ignition sources. After opening, consider re-sealing under inert gas (nitrogen or argon) to prevent moisture uptake and potential hydrolysis of the oxadiazole ring over time.
Stability: The 1,3,4-oxadiazole ring is generally stable under ambient conditions when kept dry. Prolonged exposure to strong acids, strong bases, or high humidity may cause degradation. Store away from oxidising agents and strong nucleophiles that could react with the aryl bromide.
Recommended storage temperature: Room temperature to 4 °C (consult the product label for the specific recommendation for B179918).
Waste disposal: Dispose of this compound and contaminated materials in accordance with local, national, and institutional regulations for organic chemical waste. Do not pour into drains or waterways. Use appropriate labelled waste containers.
Review flag: Specific stability data, shelf-life, and recommended storage temperature for B179918 were not confirmed in the source material and should be verified with Aladdin Scientific or from the product certificate of analysis.
Frequently asked questions
What solvents are recommended for dissolving 2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole?
DMSO and DMF are generally recommended for preparing stock solutions of oxadiazole-pyridine compounds due to their high solvating power. For synthetic purposes, DCM and ethyl acetate are also suitable. Specific solubility data for B179918 should be verified experimentally, as exact values were not confirmed in available source material.
Can 2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole be used in Suzuki cross-coupling reactions?
Yes. The aryl bromide on the pyridine ring serves as an electrophilic coupling partner in palladium-catalysed Suzuki–Miyaura coupling with boronic acids and boronate esters. Standard conditions using Pd(PPh₃)₄ or Pd(dppf)Cl₂ with a carbonate base in DMF/water at 80–100 °C are typically applicable to such substrates.
How should B179918 be stored to maintain its integrity?
Store in a tightly sealed container in a cool, dry area away from light, moisture, and strong oxidising agents. After opening, re-seal under an inert atmosphere (nitrogen or argon) to protect the aryl bromide and oxadiazole functionalities from degradation. Consult the product label for the specific recommended storage temperature.
What is the primary use of 2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole in research?
This compound serves as a versatile building block in medicinal chemistry and drug discovery. Its oxadiazole-pyridine scaffold is of interest in the design of bioactive molecules, while the aryl bromide provides a handle for further structural diversification via cross-coupling chemistry.
References
- Aladdin Scientific product page: 2-(5-Bromopyridin-3-yl)-5-propyl-1,3,4-oxadiazole, SKU B179918.
- General reference: Larock, R. C. Comprehensive Organic Transformations. 2nd ed. Wiley-VCH, 1999. (Cross-coupling reactions of aryl bromides.)
- Miyaura, N.; Suzuki, A. Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds. Chem. Rev. 1995, 95, 2457–2483. doi:10.1021/cr00039a007
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)